THESE FORMS WILL BE USED BY
INVESTIGATORS AND THEIR DESIGNEES (PHARMACISTS AND NURSES) TO TRACK
TH DISPENSING OF NCI-SPONSORED INVESTIGATIONAL NEW DRUGS UNDER NCI
CLINIC PROTOCOLS. THESE FORMS WILL SERVE AS A LINK BETWEEN THE NCI
DRUG DISTRIBUTION DATA AND THE PROTOCOL PATIENT DATA TO ENSURE THAT
INVESTIGATIONAL DRUGS ARE BEING USED PROPERLY, IN ACCORDANCE WITH
THE NOTICE(S) OF CLAIMED INVESTIGATIONAL EXEMPTION FOR A NEW DRUG",
FILED
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.